Patent US2110928A successfully refreshed from Google Patents.
← Back to Patent Explorer
US6458375B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Malleable paste with allograft bone reinforcement for filling bone defects

Assignee: Musculoskeletal Transplant Foundation
•
Filing: 2000-10-03
•
Granted: 2002-10-01
•
Expires: 2020-10-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention is directed toward a sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a mixture of demineralized osteogenic bone powder with a particle size ranging from about 250 to about 750 microns and surface demineralized cortical bone rods having a diameter ranging from 1.0 mm to 5.00 mm or larger bone chips. The surface demineralized cortical bone rods have diameter to length ratio ranging from 1:2 to 1:20. The demineralized bone powder range from about 25 to about 30% of the weight of the composition and the cortical bone rods range from 5% to about 10% of the weight of the composition with the carrier being selected from the high molecular weight hydrogel in aqueous solution having a high molecular weight over 700,000 Daltons and ranging from about 2.0% to about 5.0% by weight of the carrier solution.

Inventors

  • 👤 Arthur A. Gertzman
  • 👤 Moon Hae Sunwoo

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:58
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/32; A61F; A61F2/00; A61F2/02; A61F2/28; A61K38/00; A61K38/16; A61K38/17; A61K38/18; A61K38/1875; A61L; A61L24/00; A61L24/0005; A61L24/001; A61L24/0031; A61L24/0047; A61L24/0073; A61L24/0094; A61L27/00; A61L27/36; A61L27/3604; A61L27/3608; A61L27/3641; A61L27/3645; A61L27/365; A61L27/38; A61L27/3839; A61L27/3843; A61L27/3847; A61L27/40; A61L27/44; A61L27/48; A61L27/50; A61L27/52; A61L31/00; A61L31/005; C; C08; C08L; C08L5/00; C08L5/08; A61B; A61B17/00; A61B17/56; A61B17/58; A61B17/68; A61B17/84; A61B17/86; A61F2/30; A61F2/3094; A61F2/44; A61F2/4455; A61F2/446; A61F2/447; A61F2002/2817; A61F2002/2835; A61F2002/2839; A61F2002/30001; A61F2002/30003; A61F2002/30004; A61F2002/30059; A61F2002/30108; A61F2002/30199; A61F2002/302; A61F2002/30224; A61F2002/3023; A61F2002/30261; A61F2/30767; A61F2/30771; A61F2002/30841; A61F2002/30843; A61F2002/30878; A61F2002/30891; A61F2002/30892; A61F2002/30894; A61F2230/00; A61F2230/0063; A61F2230/0065; A61F2230/0069; A61F2230/0082; A61F2310/00; A61F2310/00005; A61F2310/00179; A61F2310/00293; A61L2430/00; A61L2430/02

Claims Analysis

Total Claims: 58
Claim 1
Independent Claim 154 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a mixture of demineralized osteogenic or osteoconductive bone powder with a particle size ranging from about 250 to about 750 microns and osteogenic bone chips of a larger size ranging from 0.1 to 10 mm in a carrier, the demineralized bone powder ranging from about 15% to about 35% of the weight of the composition and the osteogenic bone chips ranging from 5% to about 20% of the weight of the composition, the carrier being selected from a aqueous sodium based phosphate buffered solution and a hydrogel consisting of a mucopolysaccharide, said mucopolysaccharide having a high molecular weight ranging from seven hundred thousand to three million Daltons and ranging from about 2.0% to about 5.0% by weight of the carrier solution, said composition having a pH ranging from about 7.2 to about 7.4.
Claim 2
Dependent Claim 154 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a mixture of demineralized osteogenic or osteoconductive bone powder with a particle size ranging from about 250 to about 750 microns and osteogenic bone chips of a larger size ranging from 0.1 to 10 mm in a carrier, the demineralized bone powder ranging from about 15% to about 35% of the weight of the composition and the osteogenic bone chips ranging from 5% to about 20% of the weight of the composition, the carrier being selected from a aqueous sodium based phosphate buffered solution and a hydrogel consisting of a mucopolysaccharide, said mucopolysaccharide having a high molecular weight ranging from seven hundred thousand to three million Daltons and ranging from about 2.0% to about 5.0% by weight of the carrier solution, said composition having a pH ranging from about 7.2 to about 7.4.
Claim 3
Dependent Claim 18 words
A sterile malleable bone composition as claimed in claim 1 wherein said composition includes added bone morphogenic proteins.
Claim 4
Dependent Claim 27 words
A sterile malleable bone composition as claimed in claim 1 wherein said phosphate includes two phosphate ions HPO 4 −2 and H 2 PO 4 −1 .
Claim 5
Dependent Claim 21 words
A sterile malleable bone composition as claimed in claim 1 wherein said composition has an isotonic state of about 300 mOsmol/Kg.
Claim 6
Dependent Claim 20 words
A sterile malleable bone composition as claimed in claim 1 comprising the addition of a calcium salt to the carrier.
Claim 7
Dependent Claim 29 words
A sterile malleable bone composition as claimed in claim 1 wherein the balance of the carrier formulation contains a sodium phosphate buffer and has a pH of about 7.2.
Claim 8
Dependent Claim 19 words
A sterile malleable bone composition as claimed in claim 1 wherein said bone powder is cortical allograft bone powder.
Claim 9
Dependent Claim 19 words
A sterile malleable bone composition as claimed in claim 1 wherein said bone powder is cortical-cancellous allograft bone powder.
Claim 10
Dependent Claim 19 words
A sterile malleable bone composition as claimed in claim 1 wherein said bone chips are cortical allograft bone chips.
Claim 11
Dependent Claim 19 words
A sterile malleable bone composition as claimed in claim 1 wherein said bone chips are cortical-cancellous allograft bone chips.
Claim 12
Dependent Claim 19 words
A sterile malleable bone composition as claimed in claim 1 wherein said bone chips are mineralized allograft bone chips.
Claim 13
Dependent Claim 19 words
A sterile malleable bone composition as claimed in claim 1 wherein said bone chips are demineralized allograft bone chips.
Claim 14
Dependent Claim 44 words
A sterile malleable bone composition as claimed in claim 1 wherein antimicrobial and/or antibiotics selected from the group consisting essentially of erythromycin, bacitracin, neomycin, penicillin, polymyxin B, tetracycline, viomycin, chloromycetin and streptomycin, cefazolin, ampicillin, azactam, tobramycin, clindamycin and gentamycin are added to said composition.
Claim 15
Dependent Claim 16 words
A sterile malleable bone composition as claimed in claim 1 wherein said hydrogel is sodium hyaluronate.
Claim 16
Dependent Claim 15 words
A sterile malleable bone composition as claimed in claim 1 wherein said hydrogel is chitosan.
Claim 17
Dependent Claim 21 words
A sterile malleable bone composition as claimed in claim 1 wherein said composition has a pH ranging from 6.8 to 7.4.
Claim 18
Dependent Claim 21 words
A sterile malleable bone composition as claimed in claim 1 wherein the aqueous solution includes an ionic salt based phosphate buffer.
Claim 19
Dependent Claim 22 words
A sterile malleable bone composition as claimed in claim 1 wherein said hydrogel has a molecular weight of at least 700,000 Daltons.
Claim 20
Dependent Claim 23 words
A sterile malleable bone composition as claimed in claim 1 wherein said hydrogel has a molecular weight of at least of 1,000,000 Daltons.
Claim 21
Dependent Claim 22 words
A sterile malleable bone composition as claimed in claim 1 wherein said hydrogel consists of the group of sodium hyaluronate and chitosan.
Claim 22
Dependent Claim 21 words
A sterile malleable bone composition as claimed in claim 1 wherein said hydrogel substantially maintains its viscosity from 22-37 degrees C.
Claim 23
Dependent Claim 16 words
A sterile malleable bone composition as claimed in claim 1 wherein said aqueous solution is saline.
Claim 24
Dependent Claim 164 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a carrier and a mixture of demineralized osteogenic bone powder with a particle size ranging from about 250 to about 1000 microns and cortical bone rods having a length ranging from 1 mm to about 10 mm and a thickness to length ratio ranging of about 1:2 to 1:20, the demineralized bone powder ranging from about 15 to about 30% of the weight of the composition and the cortical bone rods ranging from 5% to about 20% of the weight of the composition, said carrier comprising a hydrogel selected from a group consisting of sodium hyaluronate, chitosan and carboxy-methyl-cellulose in saline phosphate buffer solution, said hydrogel having a high molecular weight ranging from about seven hundred thousand to about three million Daltons and ranging from about 2.0% to about 5.0% by weight of the carrier solution, said composition having a substantially neutral osmolality.
Claim 25
Dependent Claim 164 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a carrier and a mixture of demineralized osteogenic bone powder with a particle size ranging from about 250 to about 1000 microns and cortical bone rods having a length ranging from 1 mm to about 10 mm and a thickness to length ratio ranging of about 1:2 to 1:20, the demineralized bone powder ranging from about 15 to about 30% of the weight of the composition and the cortical bone rods ranging from 5% to about 20% of the weight of the composition, said carrier comprising a hydrogel selected from a group consisting of sodium hyaluronate, chitosan and carboxy-methyl-cellulose in saline phosphate buffer solution, said hydrogel having a high molecular weight ranging from about seven hundred thousand to about three million Daltons and ranging from about 2.0% to about 5.0% by weight of the carrier solution, said composition having a substantially neutral osmolality.
Claim 26
Dependent Claim 19 words
A sterile malleable bone composition as claimed in claim 23 wherein said composition mixture includes added bone morphogenic proteins.
Claim 27
Dependent Claim 28 words
A sterile malleable bone composition as claimed in claim 23 wherein said phosphate buffer includes two phosphate ions HPO 4 −2 and H 2 PO 4 −1 .
Claim 28
Dependent Claim 21 words
A sterile malleable bone composition as claimed in claim 23 wherein said composition has an isotonic state of about 300 mOsmol/Kg.
Claim 29
Dependent Claim 22 words
A sterile malleable bone composition as claimed in claim 23 wherein said bone rods are orientated in one direction in said composition.
Claim 30
Dependent Claim 44 words
A sterile malleable bone composition as claimed in claim 23 wherein antimicrobial and/or antibiotics selected from the group consisting essentially of erythromycin, bacitracin, neomycin, penicillin, polymyxin B, tetracycline, viomycin, chloromycetin and streptomycin, cefazolin, ampicillin, azactam, tobramycin, clindamycin and gentamycin are added to said composition.
Claim 31
Dependent Claim 23 words
A sterile malleable bone composition as claimed in claim 23 wherein said hydrogel has a molecular weight of at least one million Daltons.
Claim 32
Dependent Claim 25 words
A sterile malleable bone composition as claimed in claim 23 wherein said bone rods have a diameter ranging from 0.4 mm to about 2.0 mm.
Claim 33
Dependent Claim 18 words
A sterile malleable bone composition as claimed in claim 23 wherein said cortical bone rods are partially demineralized.
Claim 34
Dependent Claim 25 words
A sterile malleable bone composition as claimed in claim 31 wherein said bone rods have a diameter ranging from 3.0 mm to about 5.00 mm.
Claim 35
Dependent Claim 20 words
A sterile malleable bone composition as claimed in claim 23 wherein said cortical bone rods are fully demineralized and flexible.
Claim 36
Dependent Claim 21 words
A sterile malleable bone composition as claimed in claim 23 wherein said cortical bone rods are randomly orientated in said composition.
Claim 37
Dependent Claim 142 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a carrier and a mixture of demineralized osteogenic bone powder with a particle size ranging from about 250 to about 750 microns and surface demineralized cortical bone rods having a diameter ranging from 1.0 mm to 5.00 mm with a diameter to length ratio ranging from 1:2 to 1:20, the demineralized bone powder ranging from about 25 to about 30% of the weight of the composition and the cortical bone rods ranging from 5% to about 10% of the weight of the composition, said carrier comprising a high molecular weight hydrogel mucosaccharide in aqueous phosphate buffered solution, said mucosaccharide having a high molecular weight over 700,000 Daltons and ranging from about 2.0% to about 5.0% by weight of the carrier solution.
Claim 38
Dependent Claim 142 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a carrier and a mixture of demineralized osteogenic bone powder with a particle size ranging from about 250 to about 750 microns and surface demineralized cortical bone rods having a diameter ranging from 1.0 mm to 5.00 mm with a diameter to length ratio ranging from 1:2 to 1:20, the demineralized bone powder ranging from about 25 to about 30% of the weight of the composition and the cortical bone rods ranging from 5% to about 10% of the weight of the composition, said carrier comprising a high molecular weight hydrogel mucosaccharide in aqueous phosphate buffered solution, said mucosaccharide having a high molecular weight over 700,000 Daltons and ranging from about 2.0% to about 5.0% by weight of the carrier solution.
Claim 39
Dependent Claim 21 words
A sterile malleable bone composition as claimed in claim 35 wherein said cortical bone rods are randomly oriented in said composition.
Claim 40
Dependent Claim 23 words
A sterile malleable bone composition as claimed in claim 35 wherein said cortical bone rods are oriented in one direction in said composition.
Claim 41
Dependent Claim 153 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a carrier and a mixture of demineralized osteogenic bone powder with a particle size ranging from about 250 to about 1000 microns and mineral cortical bone rods having a diameter ranging from 0.4 to about 2.0 mm and a diameter to length ratio of about 2- to about 6, the demineralized bone powder ranging from about 25 to about 35% of the weight of the composition and the mineralized cortical rods ranging from 5% to about 25% of the weight of the composition, said carrier comprising a hydrogel selected from a group consisting of sodium hyaluronate, chitosan and carboxy-methyl-cellulose in a buffered phosphate saline solution, said hydrogel having a high molecular weight of at least 1.0-10 6 Daltons and ranging from about 1.0% to about 5.0% by weight of the carrier solution.
Claim 42
Dependent Claim 153 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a carrier and a mixture of demineralized osteogenic bone powder with a particle size ranging from about 250 to about 1000 microns and mineral cortical bone rods having a diameter ranging from 0.4 to about 2.0 mm and a diameter to length ratio of about 2- to about 6, the demineralized bone powder ranging from about 25 to about 35% of the weight of the composition and the mineralized cortical rods ranging from 5% to about 25% of the weight of the composition, said carrier comprising a hydrogel selected from a group consisting of sodium hyaluronate, chitosan and carboxy-methyl-cellulose in a buffered phosphate saline solution, said hydrogel having a high molecular weight of at least 1.0-10 6 Daltons and ranging from about 1.0% to about 5.0% by weight of the carrier solution.
Claim 43
Dependent Claim 130 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing mixture of demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized cortical allograft bone chips ranging from 1.0 mm to 10.00 mm in size and cortical bone rods in a hyaluronic acid saline phosphate buffer carrier, the hyaluronic acid component ranging from above 2.0% to about 5% of the carrier solution and having a molecular weight of at least 1.0×10 6 Daltons, the total bone content of the bone powder, bone chips and bone rods in the carrier ranging in weight from about 30% to about 50% total weight of the composition.
Claim 44
Dependent Claim 130 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing mixture of demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized cortical allograft bone chips ranging from 1.0 mm to 10.00 mm in size and cortical bone rods in a hyaluronic acid saline phosphate buffer carrier, the hyaluronic acid component ranging from above 2.0% to about 5% of the carrier solution and having a molecular weight of at least 1.0×10 6 Daltons, the total bone content of the bone powder, bone chips and bone rods in the carrier ranging in weight from about 30% to about 50% total weight of the composition.
Claim 45
Dependent Claim 110 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site comprising a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized bone chips ranging from 0.1 mm-10 mm in a high molecular weight sodium hyaluronate and saline carrier with a phosphate buffer, the bone content of the composition ranging from about 25% to about 45% by weight and the high molecular weight sodium hyaluronate component ranges from about 2% to about 5% of the carrier and has a molecular weight greater than one million Daltons.
Claim 46
Dependent Claim 110 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site comprising a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized bone chips ranging from 0.1 mm-10 mm in a high molecular weight sodium hyaluronate and saline carrier with a phosphate buffer, the bone content of the composition ranging from about 25% to about 45% by weight and the high molecular weight sodium hyaluronate component ranges from about 2% to about 5% of the carrier and has a molecular weight greater than one million Daltons.
Claim 47
Dependent Claim 117 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized bone chips ranging from 1-10 mm in size in a carrier solution, said carrier solution comprising a high molecular weight chitosan having a molecular weight over 1.0×10 5 Daltons in an aqueous buffered phosphate with the bone content of the putty composition ranging from about 30% to about 35% and the chitosan component ranging from 2 to 5% of the carrier solution and said composition having a substantially neutral osmolality.
Claim 48
Dependent Claim 117 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized bone chips ranging from 1-10 mm in size in a carrier solution, said carrier solution comprising a high molecular weight chitosan having a molecular weight over 1.0×10 5 Daltons in an aqueous buffered phosphate with the bone content of the putty composition ranging from about 30% to about 35% and the chitosan component ranging from 2 to 5% of the carrier solution and said composition having a substantially neutral osmolality.
Claim 49
Dependent Claim 124 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized bone cordical bone rods having a diameter to length ratio ranging from 1:2-1:20 mm in length in a carrier, said carrier comprising a high molecular weight chitosan having a molecular weight over 1.0×10 6 Daltons in a water phosphate buffered solution with the bone content of the putty composition ranging from about 30% to about 35% and the chitosan component ranging from 2 to 5% of the carrier solution and said composition having a substantially neutral osmolality.
Claim 50
Dependent Claim 124 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized bone cordical bone rods having a diameter to length ratio ranging from 1:2-1:20 mm in length in a carrier, said carrier comprising a high molecular weight chitosan having a molecular weight over 1.0×10 6 Daltons in a water phosphate buffered solution with the bone content of the putty composition ranging from about 30% to about 35% and the chitosan component ranging from 2 to 5% of the carrier solution and said composition having a substantially neutral osmolality.
Claim 51
Dependent Claim 17 words
A sterile malleable bone putty as claimed in claim 42 wherein said cortical bone rods are mineralized.
Claim 52
Dependent Claim 18 words
A sterile malleable bone putty as claimed in claim 42 wherein said cortical bone rods are partially demineralized.
Claim 53
Dependent Claim 18 words
A sterile malleable bone putty as claimed in claim 42 wherein said cortical bone rods are fully demineralized.
Claim 54
Dependent Claim 101 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized bone cordical bone rods having a diameter to length ratio ranging from 1:2-1:20 mm in length in a high molecular weight carboxy-methyl-cellulose phosphate buffered water carrier solution with the bone content of the putty composition ranging up to 30% and the carboxy-methyl-cellulose component ranging from 2 to 5% by weight of the carrier solution.
Claim 55
Dependent Claim 101 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 750 microns and mineralized bone cordical bone rods having a diameter to length ratio ranging from 1:2-1:20 mm in length in a high molecular weight carboxy-methyl-cellulose phosphate buffered water carrier solution with the bone content of the putty composition ranging up to 30% and the carboxy-methyl-cellulose component ranging from 2 to 5% by weight of the carrier solution.
Claim 56
Dependent Claim 17 words
A sterile malleable bone putty as claimed in claim 46 wherein said cortical bone rods are mineralized.
Claim 57
Dependent Claim 18 words
A sterile malleable bone putty as claimed in claim 46 wherein said cortical bone rods are partially demineralized.
Claim 58
Dependent Claim 18 words
A sterile malleable bone putty as claimed in claim 46 wherein said cortical bone rods are fully demineralized.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2005-09-30 2006-04-01 2006-10-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2009-09-30 2010-04-01 2010-10-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2013-09-30 2014-04-01 2014-10-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag